Bookmark and Share
(4-(Hydroxydiphenylmethyl)-2H-1,2,3-triazol-2-yl)(2-(methoxymethyl)piperidin-1-yl)methanone (CID 56593033) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(6)
 
 
Inactive(46)
 
 
Top Targets:
Hydrolase 4(8)
 
 
 
Peptidase S9(4)
 
 
Peptidase S9(4)
 
 
Abhydrolase 2(2)
 
 
BAAT C(2)
 
 
BioAssay Types:
Confirmatory(5)
 
 
 
BioActivity Types:
IC50(2)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 6    Data Row: 52   Total Pages: 3   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103913583]
IC50 0.000137Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based cell-based gel-based Activity-Based Protein Profiling (ABPP) IC50 for anti-target ABHD11 [AID504482, Type: confirmatory]Abhydrolase domain containing 11 [Mus musculus] [gi:47682716]
View
2
[SID103913583]
IC50 0.001Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) IC50 for anti-target ABHD11 Set 2 [AID504507, Type: confirmatory]Abhydrolase domain containing 11 [Mus musculus] [gi:47682716]
View
3
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504520_1, Type: other]Abhydrolase domain containing 11 [Mus musculus] [gi:47682716]
View
4
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_1, Type: other]Abhydrolase domain containing 11 [Mus musculus] [gi:47682716]
View
5
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504520, Type: other]
View
6
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522, Type: other]
View
7
[SID103913583]
50Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: absorbance-based cell-based dose response assay to determine cytotoxicity of inhibitor compounds set 2 [AID504510_1, Type: confirmatory]
View
8
[SID103913583]
50Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: absorbance-based cell-based dose response assay to determine cytotoxicity of inhibitor compounds set 2 [AID504510_2, Type: confirmatory]
View
9
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_6, Type: other]Prepl protein [Mus musculus] [gi:13435484]
View
10
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_39, Type: other]Ddhd1 protein [Mus musculus] [gi:27694042]
View
11
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_24, Type: other]protein phosphatase methylesterase 1 [Mus musculus] [gi:30794138]
View
12
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_20, Type: other]Pnpla6 protein [Mus musculus] [gi:34784201]
View
13
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_21, Type: other]Pla2g6 protein [Mus musculus] [gi:34784362]
View
14
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_30, Type: other]Dipeptidylpeptidase 8 [Mus musculus] [gi:37590654]
View
15
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504520_5, Type: other]Esterase D/formylglutathione hydrolase [Mus musculus] [gi:55777188]
View
16
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_16, Type: other]Esterase D/formylglutathione hydrolase [Mus musculus] [gi:55777188]
View
17
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_7, Type: other]Fam108b protein [Mus musculus] [gi:61403362]
View
18
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: fluorescence-based biochemical gel-based Activity-Based Protein Profiling (ABPP) inhibition and selectivity [AID504520_3, Type: other]Lypla1 [Mus musculus] [gi:71059731]
View
19
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_32, Type: other]Lypla1 [Mus musculus] [gi:71059731]
View
20
[SID103913583]
Late stage assay provider results from the probe development effort to identify inhibitors of LYPLA1: LC-MS-based cell-based SILAC Activity-Based Protein Profiling (ABPP) for anti-target ABHD11 [AID504522_11, Type: other]Patatin-like phospholipase domain containing 8 [Mus musculus] [gi:117558667]
View